Chiron Behring Vaccines Private Limited

Chiron Behring Vaccines Private Limited - pharma in Bhor, Maharashtra, India. FY 2026 financials & compliance.
CIN U24230PN1997PTC222142 Incorporated 07 October 1997 ROC Pune HQ Bhor, Maharashtra, India
Active Private Limited Company pharma MSME · Medium
Revenue · FY 2025
₹94.53 Cr
▲ 30% YoY
Net profit · FY 2025
₹3.03 Cr
Net margin 3.2%
EBITDA · FY 2025
₹26.71 Cr
EBITDA margin 28.3%
Authorised capital
₹10 Cr
Registered with MCA
Paid-up capital
₹10 Cr
Issued & subscribed
Open charges
₹4.2 Lakh
Satisfied ₹2.46 Cr
Company age
29 yrs
Est. 1997
Employees · EPFO
207
Provident fund records

About Chiron Behring Vaccines Private Limited

Data last updated:

Chiron Behring Vaccines Private Limited is a private limited company based in Bhor, Maharashtra, India, a subsidiary of Bharat Biotech International Limited. It operates in the animal pharmaceuticals and healthcare segment of the pharmaceuticals sector. It was incorporated on 07 October 1997 and has been in existence for over 29 years.

The company is registered with the Registrar of Companies (ROC), Pune, under CIN U24230PN1997PTC222142. Its GSTIN is 09AAACC6494P1ZX (Uttar Pradesh). The company holds 5 GST registrations, of which 4 are active.

The company has an authorised share capital of ₹10 Cr and a paid-up capital of ₹10 Cr. It was formerly known as Chiron Behring Vaccines Limited. It is led by directors Sai Prasad Devarajulu (Whole-Time Director) and Raches Virendradev Ella.

Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2024. The registered office is at Bhor, Maharashtra.

As per the financials filed for FY 2025, the company reported a revenue of ₹94.53 Cr, a growth of 30% compared to the previous year. For the same year it recorded a net profit of ₹3.03 Cr (net margin 3.2%) and EBITDA of ₹26.71 Cr (EBITDA margin 28.3%). Revenue has grown at a compounded annual rate (CAGR) of 48% over three years and 20% over five years.

The company has about 207 employees on its provident fund (EPFO) records.

As per MCA filings, the company has open charges of ₹4.2 Lakh and satisfied charges of ₹2.46 Cr on record. Court records list 19 cases involving the company, including 7 filed by the company and 12 filed against it; 2 cases are pending. The company has 3 deals on record (3 secondary share transfers); the latest was in March 2019. Its 9 peer companies in the Pharma industry (Formulations, Vaccines), with the same principal business activity (chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products) are compared by revenue, 5 larger and 4 smaller; the largest is MCW Healthcare Private Limited with revenue of ₹95.35 Cr. The company has 13 MSME Form 1 returns on record between 2019 and 2024, listing 148 overdue payments to 47 micro and small suppliers.

Chiron Behring Vaccines Private Limited is registered as a medium enterprise under the Udyam registration framework (Reg. No. UDYAM-GJ-06-0018722). The current compliance status is marked as compliant by the Registrar of Companies. For more details, the company can be reached via its website chironbehring.com.

Company details

CIN U24230PN1997PTC222142
Registration Number 222142
Incorporation Date 07 October 1997
ROC Pune
Listing Status Unlisted
Company Status Active
Parent Company Bharat Biotech International Limited
Compliance Status Active Compliant
MSME Classification Medium
Udyam Registration UDYAM-GJ-06-0018722

CIN history

Chiron Behring Vaccines has one previous CIN (Corporate Identification Number): U24230MH1997PTC111122. The current CIN is U24230PN1997PTC222142, which is the unique identifier assigned by the Registrar of Companies.

CINStatus
U24230PN1997PTC222142Current
U24230MH1997PTC111122Previous
Key People
Sai Prasad Devarajulu Whole-Time Director Srinivas Tadepally Cfo Raches Virendradev Ella Director

Recognitions & Rankings of Chiron Behring Vaccines

MSME (Udyam registered) Ministry of MSME
Category
Medium (2024-25)
Udyam number
UDYAM-GJ-06-0018722

Contact details

Chiron Behring Vaccines Private Limited's registered office is in Bhor, Maharashtra. Its website is chironbehring.com. Its e-mail address and telephone number are in the company report.

  • Email
  • Telephone
  • Website
    chironbehring.com
  • Registered Address
    Survey No27 (Gatno.136) At Manjari Khurd Village, Taluka Haveli, Bhor, Maharashtra, India – 412205
  • Industry
    Pharma, Animal Pharmaceuticals & Healthcare

To see the full contact details of Chiron Behring Vaccines Private Limited, buy the company report.

Comprehensive company report
Chiron Behring Vaccines Private Limited - one report that includes everything
  • Company details, directors and signatories
  • Historical financials and ratios
  • Shareholding pattern and group structure
  • Charges with holder and property details
  • Legal cases, compliance and MCA filings
₹799 ₹999 20% off excluding 18% GST
Secure checkout · GST invoice included

Business activity

The main business activity of Chiron Behring Vaccines is manufacturing. In detail, this covers chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products.

Main activity group codeMain activityBusiness activity codeBusiness activityShare of turnover
CManufacturingC6Chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products

To see the full business activity and turnover split of Chiron Behring Vaccines Private Limited, buy the company report.

Financials of Chiron Behring Vaccines Private Limited

FY 2024 filings available

Chiron Behring Vaccines Private Limited reported revenue of ₹94.53 Cr (up 30% YoY) for FY 2025.

Revenue · FY 2025
₹94.53 Cr ▲ 30%
Net profit · FY 2025
₹3.03 Cr margin 3.2%
EBITDA · FY 2025
₹26.71 Cr margin 28.3%

Compounded Annual Growth Rate (CAGR)

Revenue CAGR growth
1 year
▲ 30%
3 years · compounded
▼ 48%
5 years · compounded
▲ 20%
EBITDA CAGR growth
1 year
▲ 171%
3 years · compounded
▼ 45%
5 years · compounded
▲ 31%

Revenue has grown at a compounded annual rate (CAGR) of 20% over five years, including 30% growth in the latest year. EBITDA rose 171% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.

Financial Statement Summary

MetricsFY 2024-25FY 2023-24FY 2022-23FY 2021-22FY 2020-21
Profit and Loss Statement
Revenue from Operations
Other Income
Total Revenue
Cost of Materials Consumed
Employee Benefit Expense
Finance Costs
Depreciation and Amortisation
Other Expenses
Total Expenses
EBITDA₹26.71 Cr
Profit Before Tax
Tax Expense
Net Profit (PAT)₹3.03 Cr
Balance Sheet
Share Capital
Reserves and Surplus
Net Worth (Total Equity)
Long-term Borrowings
Short-term Borrowings
Trade Payables
Total Liabilities
Fixed Assets
Investments
Inventories
Trade Receivables
Cash and Bank Balance
Total Assets

Financial Ratios

MetricsFY 2024-25FY 2023-24FY 2022-23FY 2021-22FY 2020-21
Profitability
EBITDA Margin28.3%
Net Profit Margin3.2%
Return on Equity (ROE)
Return on Capital Employed (ROCE)
Return on Assets (ROA)
Liquidity and Debt
Current Ratio
Quick Ratio
Debt-to-Equity Ratio
Interest Coverage Ratio
Efficiency and Growth
Asset Turnover
Receivable Days
Payable Days
Inventory Days
Revenue Growth
Net Profit Growth

To see the full financial statements and ratios of Chiron Behring Vaccines Private Limited, buy the company report.

Board of directors and KMP of Chiron Behring Vaccines Private Limited

Chiron Behring Vaccines Private Limited currently reports 2 directors and 1 key managerial person. 28 former directors have served the organization.

Current Directors and KMP
NameDesignationAppointment DateTenureStatus
Srinivas Tadepally
Also directs: Skebio Infra LLP
Cfo25 Jan 20206 Years 9 MonthsCurrent
Raches Virendradev Ella
Also directs: Sapigen Biologix Private Limited, Ella Fresh Private Limited, Ella Foods Private Limited and 4 more
Director31 Aug 20197 Years 2 MonthsCurrent
Sai Prasad Devarajulu
Also directs: Skebio Infra LLP, Bharat Biotech International Limited, RCC Laboratories India Private Limited and 4 more
Whole-Time Director01 Mar 20197 Years 8 MonthsCurrent
View all directors and KMP

Peer comparison

Chiron Behring Vaccines Private Limited is compared with the 9 companies closest to it by revenue in the Pharma industry (Formulations, Vaccines), with the same principal business activity (chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products), from the latest filed financials of each company.

CompanyRevenueNet profitMarginGrowth (1 yr)EmployeesLocation
MCW Healthcare Private Limited₹95.35 Cr (FY 2024)16.0%Madhya Pradesh, India
Surmount Laboratories Limited₹95.33 Cr (FY 2024)-6.0%Mumbai, Maharashtra, India
Ang Lifesciences India Limited₹94.87 Cr (FY 2025)-35.0%Amritsar, Punjab, India
Bio-Med Private Limited₹94.67 Cr (FY 2025)19.0%Uttar Pradesh, India
Impulse Pharma Private Limited₹94.61 Cr (FY 2024)12.0%Thane, Maharashtra, India
Chiron Behring Vaccines Private Limitedthis company₹94.53 Cr (FY 2025)₹3.03 Cr3.2%30.0%207Bhor, Maharashtra, India
Cosmas Research Lab Limited₹93.42 Cr (FY 2025)60.0%Ludhiana, Punjab, India
Centurion Healthcare Private Limited₹92.65 Cr (FY 2024)21.0%Vadodara, Gujarat, India
Lovincare Cosmetics Private Limited₹92.22 Cr (FY 2025)22.0%Himachal Pradesh, India
Chandra Bhagat Pharma Limited₹92.2 Cr (FY 2025)-60.0%Mumbai, Maharashtra, India

To see the full peer comparison of Chiron Behring Vaccines Private Limited, buy the company report.

Auditor

Chiron Behring Vaccines Private Limited is audited by Brahmayya & Co for the financial year 2024.

Auditor firmFinancial yearFirm registration number
Brahmayya & CoFY 2024000515S

Shareholding

The shareholding of Chiron Behring Vaccines Private Limited is on record for 5 financial years, the latest being FY 2024, split between promoters, domestic institutions, foreign institutions, public shareholders and others.

Shareholder categoryFY 2024FY 2023FY 2022FY 2021FY 2020
Promoters
Domestic institutional investors (DII)
Foreign institutional investors (FII)
Public
Others

To see the full shareholding pattern of Chiron Behring Vaccines Private Limited, buy the company report.

Charges & borrowings

Open charges
₹4.2 Lakh
Satisfied charges
₹2.46 Cr
Breakdown by lending institutions
Others₹0.04 Cr
Latest charge details
DateCharge IDLenderAmountStatusModified or satisfied on
11 Aug 2020100363261Others₹4.2 LakhOpen
11 Aug 2020100363260Others₹45.9 LakhSatisfied
22 Feb 199990157093Bank of America Natis Trust & Saving Assoen₹2 CrSatisfied

To see the full charge records of Chiron Behring Vaccines Private Limited, buy the company report.

Total charge records: 3 View all charges

Deals & funding

Chiron Behring Vaccines Private Limited has 3 deals on record (3 secondary share transfers); the latest was in March 2019.

Total deals
3
Secondary share transfers
3

Deals on record (3 of 3)

WhenDealAmountParties
Mar 2019Secondary share transferUndisclosedBuyer: Bharat Biotech International Limited
Seller: Glaxomithkline Asia Private Limited
Mar 2016Secondary share transferUndisclosedBuyer: Glaxomithkline Asia Private Limited, Edinburgh Pharmaceutical Indust Limited
Seller: Novartis Pharma AG, Novartis Vaccines & Diagnostics INC
Dec 2010Secondary share transferUndisclosedBuyer: Novartis Pharma AG
Seller: Sanofi India Limited

Deal records are compiled from filings and public sources; amounts are shown only where the source reported them.

MSME payment delays

Chiron Behring Vaccines Private Limited has 13 MSME Form 1 returns on record between 2019 and 2024, listing 148 overdue payments to 47 micro and small suppliers. Companies must report dues to micro and small suppliers that stay unpaid for more than 45 days in a half-yearly MSME Form 1 return.

Suppliers with reported dues (5 of 47)

SupplierAmount dueDue sinceReported on
Relicorp Logistics LLP
Tempcon Express Private Limited
Bharat Rubber Works Private Limited
Sensewell Calibration Ser
an individual supplier

To see the full MSME payment records of Chiron Behring Vaccines Private Limited, buy the company report.

Individuals and sole proprietors among the suppliers are not named.

Employees & EPFO

Chiron Behring Vaccines Private Limited has a workforce of 207 employees on its EPFO records as of May 2026, across 1 active EPFO establishment.

Employee count
207
Active EPFO establishments
1
Employee growth
7.8%

Headcount by financial year

Financial yearEmployees (EPFO)
FY 2026-27207
FY 2025-26
FY 2024-25
FY 2023-24
FY 2022-23
FY 2021-22
FY 2020-21
FY 2019-20
FY 2018-19
FY 2017-18
FY 2016-17

To see the full employee and EPFO history of Chiron Behring Vaccines Private Limited, buy the company report.

GST

Chiron Behring Vaccines has 5 GST registrations: 4 active and 1 cancelled or inactive.

Total GSTINs
5
Active
4
Cancelled / inactive
1
GSTINStateStatusRegistered on
09AAACC6494P1ZXUttar PradeshActive01 Jul 2017
24AAACC6494P1Z5GujaratActive01 Jul 2017
27AAACC6494P1ZZMaharashtraActive01 Jul 2017
27AAACC6494P2ZYMaharashtraActive05 Aug 2017

To see the full GST registrations and return filing status of Chiron Behring Vaccines Private Limited, buy the company report.

Recent activity

Chiron Behring Vaccines Private Limited has 29 board changes on record since 2007: 3 appointments and 26 cessations. The latest: Sonam Kinjal Gandhi ceased to be Company Secretary on 21 Jun 2022.

AGM
Chiron Behring Vaccines Private Limited last Annual general meeting of members was held on 30 Sep 2025 as per latest MCA records.
Filing
Chiron Behring Vaccines Private Limited has filed its annual Financial statements for the year ended 31 Mar 2024 with Roc Pune.
Ceased
Sonam Kinjal Gandhi ceased to be Company Secretary.
Ceased
Pradip Maganlal Patel ceased to be Director.
Charges
A charge registered on 11 Aug 2020 via Charge ID 100363260 with Others was fully satisfied on 29 Nov 2021.
Ceased
Sai Prasad Devarajulu ceased to be Director.
Charges
A charge with Others amounted to Rs. 0.04 Cr with Charge ID 100363261 was registered on 11 Aug 2020.
Charges
A charge with Others amounted to Rs. 0.46 Cr with Charge ID 100363260 was registered on 11 Aug 2020.
Appointed
Srinivas Tadepally was appointed as CFO.
Ceased
Ganesh Sadashiv Dhamdhere ceased to be Additional Director.
Ceased
Raches Virendradev Ella ceased to be Additional Director.
Appointed
Raches Virendradev Ella was appointed as Director.

25 earlier events are in the company report.

Frequently asked questions

Chiron Behring Vaccines is an active private limited company based in Bhor, Maharashtra, India. The company works in animal pharmaceuticals and healthcare, within the pharma industry. It was incorporated on 07 October 1997 (29+ years old) and is registered under CIN U24230PN1997PTC222142.

Chiron Behring Vaccines has 3 current directors and KMP:

The latest financial statements of Chiron Behring Vaccines on record with the MCA are for the year ended 31 March 2024. Its last annual general meeting was held on 30 September 2025. Year-wise statements from 2015 are in the company report.

The GSTIN of Chiron Behring Vaccines is 09AAACC6494P1ZX, registered in Uttar Pradesh. The company has 5 GST registrations in all, of which 4 are active and 1 is cancelled or inactive. Other active GSTINs include 24AAACC6494P1Z5 (Gujarat), 27AAACC6494P1ZZ (Maharashtra), 27AAACC6494P2ZY (Maharashtra).

The CIN (Corporate Identification Number) of Chiron Behring Vaccines is U24230PN1997PTC222142. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.

Chiron Behring Vaccines has 19 court cases on record: 7 filed by the company and 12 filed against it. 2 are pending. Most are in the high courts.

Chiron Behring Vaccines was incorporated on 07 October 1997, making it 29+ years old. It is registered with the Registrar of Companies, Pune.

Chiron Behring Vaccines has 3 deals on record (3 secondary share transfers); the latest was in March 2019.

The peers of Chiron Behring Vaccines by revenue are MCW Healthcare Private Limited, Surmount Laboratories Limited, Ang Lifesciences India Limited, Bio-Med Private Limited, Impulse Pharma Private Limited and 4 more, all in the Pharma industry (Formulations, Vaccines), with the same principal business activity (chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products).

Sonam Kinjal Gandhi ceased to be Company Secretary on 21 Jun 2022. Pradip Maganlal Patel ceased to be Director on 10 Dec 2021. Sai Prasad Devarajulu ceased to be Director on 03 Sep 2021. Chiron Behring Vaccines has 29 board changes on record in total.

Yes, Chiron Behring Vaccines is registered as a medium enterprise under Udyam registration (number: UDYAM-GJ-06-0018722).

Chiron Behring Vaccines has 13 MSME Form 1 returns on record between 2019 and 2024, listing 148 overdue payments to 47 micro and small suppliers. The latest return was filed on 29 Apr 2024.